Roche: extends collaboration with Denmark's BioPorto

(CercleFinance.com) - Danish company BioPorto announced on Tuesday that it is extending its strategic collaboration with Roche Diagnostics, Roche's in vitro diagnostics subsidiary.


BioPorto, whose test for the biomarker of pediatric acute renal failure was recently approved in the US, states that the distribution agreement with Roche will now include the cobas c 503 analytical unit.

Previously, the partnership covered the cobas c 501 and c 502 modules.

BioPorto, which develops tests for diagnosing human diseases, specialises in technologies for identifying and monitoring acute kidney injury.


Copyright (c) 2024 CercleFinance.com. All rights reserved.